| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.14B | 20.26B | 16.04B | 15.63B | 17.37B | 15.54B |
| Gross Profit | 4.56B | 5.73B | 4.50B | 4.63B | 4.98B | 4.60B |
| EBITDA | 2.09B | 2.93B | 2.01B | 2.32B | 2.88B | 2.49B |
| Net Income | 577.62M | 1.07B | 591.47M | 1.04B | 1.33B | 1.26B |
Balance Sheet | ||||||
| Total Assets | 20.52B | 26.02B | 20.64B | 21.12B | 20.84B | 21.38B |
| Cash, Cash Equivalents and Short-Term Investments | 1.67B | 2.16B | 1.63B | 2.74B | 2.98B | 3.22B |
| Total Debt | 4.91B | 7.98B | 5.06B | 5.34B | 6.39B | 7.30B |
| Total Liabilities | 8.03B | 12.54B | 8.12B | 9.04B | 9.81B | 11.61B |
| Stockholders Equity | 12.30B | 13.33B | 12.33B | 12.04B | 11.00B | 9.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.94B | -752.22M | 850.13M | 675.39M | -627.90M |
| Operating Cash Flow | 0.00 | 1.94B | 1.67B | 2.04B | 2.62B | 1.27B |
| Investing Cash Flow | 0.00 | -3.76B | -2.34B | -1.07B | -1.82B | -1.84B |
| Financing Cash Flow | 0.00 | 1.46B | -450.68M | -1.20B | -1.04B | 2.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥203.83B | 22.33 | 11.00% | 2.20% | 6.75% | -0.16% | |
73 Outperform | ¥25.59B | 8.53 | ― | 2.62% | -14.20% | 231.20% | |
72 Outperform | ¥428.04B | 24.29 | ― | 1.30% | 9.57% | 9.73% | |
67 Neutral | ¥7.06B | 57.57 | ― | 1.36% | -4.59% | -14.60% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥11.51B | 13.20 | ― | 1.87% | 26.33% | 81.16% | |
56 Neutral | ¥2.32B | 2.45 | ― | 1.93% | -22.86% | -86.49% |